Abstract:Since its initial identification, the Forkhead Box P2 gene ( FOXP2 ) has maintained its singular status as the archetypal monogenic determinant implicated in Mendelian forms of human speech and language impairments. Despite the passage of two decades subsequent to its discovery, extant literature remains disproportionately sparse with regard to case-specific instances and loci of mutational perturbations. The objective of the current investigation centers on furnishing an enriched delineation of both its clinical manifestations and its mutational heterogeneity. Clinical phenotypes and peripheral blood samples were assiduously amassed from familial subjects. Whole-exome sequencing and Sanger sequencing methodologies were deployed for the unambiguous identification of potential genetic variants and for corroborating their co-segregation within the family pedigree. An exhaustive review of published literature focusing on patients manifesting speech and language disorders consequent to FOXP2 genetic anomalies was also undertaken. The investigation yielded the identification of a novel heterozygous variant, c.661del (p.L221Ffs*41), localized within the FOXP2 gene in the proband, an inheritance from his symptomatic mother. The proband presented with an array of symptoms, encompassing dysarthric speech, deficits in instruction comprehension, and communicative impediments. In comparison, the mother exhibited attenuated symptoms, including rudimentary verbalization capabilities punctuated by pronounced stuttering and dysarthria. A comprehensive analysis of articles archived in the Human Gene Mutation Database (HGMD) classified under "DM" disclosed the existence of 74 patients inclusive of the subjects under current examination, sub-divided into 19 patients with null variants, 5 patients with missense variants, and 50 patients with gross deletions or complex genomic rearrangements. A conspicuous predominance of delayed speech, impoverished current verbal abilities, verbal comprehension deficits, and learning difficulties were observed in patients harboring null or missense FOXP2 variants, as compared to their counterparts with gross deletions or complex rearrangements. Developmental delays, hypotonia, and craniofacial aberrations were exclusive to the latter cohort. The elucidated findings augment the existing corpus of knowledge on the genetic architecture influencing both the proband and his mother within this specified familial context. Of critical importance, these discoveries furnish a robust molecular framework conducive to the prenatal diagnostic evaluations of prospective progeny within this familial lineage.

Case Report: Expressive Speech Disorder in a Family as a Hallmark of 7q31 Deletion Involving the FOXP2 Gene

7q31.2q31.31 deletion downstream of FOXP2 segregating in a family with speech and language disorder

Childhood Apraxia of Speech (CAS) in two patients with 16p11.2 microdeletion syndrome

Novel FOXP2 variant associated with speech and language dysfunction in a Chinese family and literature review

Case Report: FOXP1 Syndrome Caused by a De Novo Splicing Variant (c.1652+5 G>A) of the FOXP1 Gene.

FOXP2 gene deletion and infant feeding difficulties: a case report

Identification of a Novel FOXP1 Variant in a Patient with Hypotonia, Intellectual Disability, and Severe Speech Impairment

Early neuroimaging markers of FOXP2 intragenic deletion

Case Report of Suspected Gonadal Mosaicism in FOXP1-Related Neurodevelopmental Disorder

Genome Sequencing of Idiopathic Speech Delay

Two new cases of interstitial 7q35q36.1 deletion including CNTNAP2 and KMT2C

Fourteen new cases contribute to the characterization of the 7q11.23 microduplication syndrome

The phenotype of recurrent 10q22q23 deletions and duplications

22q13 deletion syndrome: communication disorder or autism? Evidence from a specific clinical and neurophysiological phenotype

Case Report: Congenital Brain Dysplasia, Developmental Delay and Intellectual Disability in a Patient With a 7q35-7q36.3 Deletion

Duplication of C7orf58, WNT16 and FAM3C in an Obese Female with a T(7;22)(q32.1;q11.2) Chromosomal Translocation and Clinical Features Resembling Coffin-Siris Syndrome

Phenotypic and molecular characterization of 19q12q13.1 deletions: A report of five patients

Implications of a Chr7q21.11 Microdeletion and the Role of the PCLO Gene in Developmental Delay

Severe childhood speech disorder: Gene discovery highlights transcriptional dysregulation

22q13.33 duplication involving SHANK3 gene: a boy and his mother with "persistent" language and speech sound disorder

4Q27 Deletion and 7q36.1 Microduplication in a Patient with Multiple Malformations and Hearing Loss: a Case Report